Sorry but you won't be going it alone with $55 million, this is posturing and promoting revenue to get Z on everyone's radar while waiting on CKD phase II results. I think the spectacular phase III results paint a picture that this baby is going to shine in CKD as well, and we all know that we would be only drug in class. Good luck longs.
Good points, Del. Ron has erased the fear of a dwindling cash position at a time of PPS strength when the existing shareholders may not even feel the pinch of the cash raise. The predialysis Phase II is an even bigger prize than the grand win we just secured with the Phase III dialysis trial. We will have no cash worries going forward now if it takes longer to sell the company than we shareholders think.LOL The Phase II pre-D should be finishing up around June. If that Phase II trial demonstrates the same Zerenex effects as in the just completed Phase III (with no reasons it shouldn't), we will officially have a Blockbuster drug and any leftover cash will be a "deal sweetner" in the buyout negotiations. If you have to say only one thing about Benstur, it is that he has put his shareholders first and foremost.